BMRN
Biomarin Pharmaceutical Inc.
Biotechnology company focused on developing and commercializing therapies for rare genetic diseases
CUSIP: 09061G101HealthcareUS4 holders
Total Value
$1.61B
Total Shares
19.51M
Net Share Change
+678.9K
Activity
2 buying
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$733.89M8.91M sharesUnchanged
